肿瘤相关巨噬细胞来源的 CCL18 通过 PITPNM3 促进乳腺癌转移。

CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3.

机构信息

Breast Tumor Center, Sun-Yat-Sen Memorial Hospital, Sun-Yat-Sen University, Guangzhou, China.

出版信息

Cancer Cell. 2011 Apr 12;19(4):541-55. doi: 10.1016/j.ccr.2011.02.006.

Abstract

Tumor-associated macrophages (TAMs) can influence cancer progression and metastasis, but the mechanism remains unclear. Here, we show that breast TAMs abundantly produce CCL18, and its expression in blood or cancer stroma is associated with metastasis and reduced patient survival. CCL18 released by breast TAMs promotes the invasiveness of cancer cells by triggering integrin clustering and enhancing their adherence to extracellular matrix. Furthermore, we identify PITPNM3 as a functional receptor for CCL18 that mediates CCL18 effect and activates intracellular calcium signaling. CCL18 promotes the invasion and metastasis of breast cancer xenografts, whereas suppressing PITPNM3 abrogates these effects. These findings indicate that CCL18 derived from TAMs plays a critical role in promoting breast cancer metastasis via its receptor, PITPNM3.

摘要

肿瘤相关巨噬细胞(TAMs)可以影响癌症的进展和转移,但具体机制尚不清楚。在这里,我们发现乳腺癌 TAMs 大量产生 CCL18,其在血液或肿瘤基质中的表达与转移和患者生存时间缩短有关。乳腺癌 TAMs 释放的 CCL18 通过触发整合素聚集并增强其与细胞外基质的黏附,促进癌细胞的侵袭。此外,我们确定 PITPNM3 是 CCL18 的功能受体,它介导 CCL18 的作用并激活细胞内钙信号。CCL18 促进乳腺癌异种移植物的侵袭和转移,而抑制 PITPNM3 则消除了这些作用。这些发现表明,TAMs 衍生的 CCL18 通过其受体 PITPNM3 在促进乳腺癌转移中发挥关键作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索